兽医费用飙升，私募股权收购诊所引关注

Y FRIEND YOU MIGHT HAVE NOTICED VETERINARY CARE IS BECOMING INCREASINGLY EXPENSIVE. AS PRICES RISE ATTENTION IS TURNING TO A MAJOR SHIFT IN THE INDUSTRY. PRIVATE EQUITY FIRMS IN LARGE CORPORATIONS ARE BUYING UP VETERINARY PRACTICES ACROSS THE COUNTRY. PAUL: A NINE-YEAR-OLD BOXER WHO LIVED IN CALIFORNIA.

I ADOPTED HIM IN APRIL OF 2020. A PANDEMIC BABY. HE WAS IN MOSTLY GOOD HEALTH FOR ABOUT A YEAR AND THEN HE STARTED VOMITING REGULARLY. PAUL: AFTER A YEAR-PLUS OF THAT VISITS, CLYDE'S DIAGNOSIS -- CANCER.

WE

STARTED HIM ON CHEMO EARLIER. IN 2026 I HAVE SPENT $3500.

AT WHAT POINT DO YOU SAY, ENOUGH? PAUL: JENNIFER HAS SPENT $20,000 ON HER DAUGHTER'S BELOVED 14-YEAR-OLD CAT.

IF IT WAS $20,000 ALL AT ONCE I MIGHT HAVE SAID NO. BECAUSE IT WAS A FEW THOUSAND, IF YOU THOUSAND, AND THEN A FEW YEARS PAST AND THEN A FEW THOUSAND, IT IS HARD TO DRAW A CLEAR LINE. PAUL: WE CAN BOMBARD YOU WITH STORIES LIKE THESE BECAUSE VETERINARY CARE COSTS HAVE RISEN BY ROUGHLY 60% SINCE 2014, FAR OUTPACING OVERALL INFLATION. THE MISSION OF THIS STORY -- TO EXAMINE THE ROLE OF CORPORATE OWNERSHIP BY PRIVATE EQUITY IN PARTICULAR.

RISING PRICES ARE PARTLY A STORY OF INFLATION, PARTLY A STORY OF BETTER MEDICINE, PARTLY A STORY OF LABOR SCARCITY AND PARTLY A STORY OF OWNERSHIP AND MARKET STRUCTURE. PAUL: AN ECONOMIST STUDIES THE INDUSTRY.

THE PRIVATE EQUITY COMPONENT IS A PIECE OF THAT STORY. PAUL: THEY ARE REAL ENOUGH. IN FACT, CLYDE AND JUPITER HAVE SOMETHING IN COMMON. THEY WERE TREATED BY VETS OWNED BY THE SAME PRIVATE EQUITY FIRM. AS WE AND OTHERS HAVE REPORTED, PRIVATE EQUITY BUYS BUSINESSES TO HIKE THEIR VALUE. THE GOAL -- INCREASE PROFITS AND SELL AT A HIGHER PRICE.

PRIVATE EQUITY HAS STARTED TO MOVE IN VERY AGGRESSIVELY. INTO THE VETERINARIAN SPACE.

A FINANCIAL JOURNALIST.

WHAT OFTEN HAPPENS IS EVERYONE FROM THE CUSTOMERS TO THE EMPLOYEES GET THE SHORT END OF THE STICK. THERE IS A LOT OF EVIDENCE OUT THERE NOW THAT WHAT THEY DO IS PUT A LOT OF PRESSURE ON THE VETERINARIAN CLINICS THEMSELVES TO INCREASE REVENUE. THEY RAISE PRICES QUICKLY AND OFTEN. PAUL: IN THE VET WORLD, SO MUCH DEPENDS ON HOW THE ACQUIRERS OPERATE AND HOW MANY PRACTICES THEY OWN.

THE ENTRY OF PRIVATE EQUITY IS NOT GOOD OR BAD. IT IS WHAT KIND OF OPERATING MODEL. THE PROBLEM HERE IS ONE OF SIZE. IT IS EASIER FOR A SMALLER ENTERPRISE TO MAINTAIN THAT LEVEL OF TRUST BETWEEN THE VETERINARIAN TEAM AND THE PET OWNER BECAUSE THE DISTANCE BETWEEN DECISION-MAKER AND DECISION IMPLEMENTER IS CLOSER. THAT BECOMES HARDER AS AN ENTERPRISE GROWS THAT CAN HAPPEN IN A CORPORATE VENDOR PRACTICE. PAUL: IN OTHER WORDS THE PRACTICE TO PUT PROFITS OVER PETS.

A GOVERNMENT-BACKED INVESTIGATION IN THE U.K. ESTIMATED CORPORATE OWNERSHIP ADDED MORE THAN $1 BILLION IN COSTS FOR CONSUMERS OVER A FIVE-YEAR PERIOD. BACK YOUR ACROSS THE POND CORPORATIONS OWNED ONLY 10% OF THAT PRACTICE IS A DECADE AGO. TODAY IT IS ESTIMATED FROM 30% TO 50%. AND SPECIALTY CARE -- EMERGENCY MEDICINE, ONCOLOGY AND CARDIO